Ibalizumab-uiyk is used with other medications to treat human immunodeficiency virus (HIV) infection in adults who have been treated with several other HIV medications in the past and whose HIV could not be successfully be treated with other medications, including their current therapy. Ibalizumab-uiyk is in a class of medications called monoclonal antibodies. It works by blocking HIV from infecting cells in the body. Although ibalizumab-uiyk does not cure HIV, it may decrease your chance of developing acquired immunodeficiency syndrome (AIDS) and HIV-related illnesses such as serious infections or cancer. Taking these medications along with practicing safer sex and making other life-style changes may decrease the risk of transmitting (spreading) the HIV virus to other people.
Ibalizumab-uiyk comes as solution (liquid) to be injected intravenously (into a vein) over 15 to 30 minutes by a doctor or nurse. It is usually given once every 2 weeks. A doctor or nurse will watch you carefully for side effects while the medication is being infused, and for up to an 1 hour afterwards.
Ask your pharmacist or doctor for a copy of the manufacturer's information for the patient.
This medication may be prescribed for other uses; ask your doctor or pharmacist for more information.
Before taking ibalizumab-uiyk injection,
Unless your doctor tells you otherwise, continue your normal diet.
Keep all appointments with your doctor and the laboratory. Your doctor will/may order certain lab tests to check your body's response to ibalizumab-uiyk injection.
It is important for you to keep a written list of all of the prescription and nonprescription (over-the-counter) medicines you are taking, as well as any products such as vitamins, minerals, or other dietary supplements. You should bring this list with you each time you visit a doctor or if you are admitted to a hospital. It is also important information to carry with you in case of emergencies.
AHFS® Consumer Medication Information. © Copyright, The American Society of Health-System Pharmacists, Inc., 7272 Wisconsin Avenue, Bethesda, Maryland. All Rights Reserved. Duplication for commercial use must be authorized by ASHP.
Selected Revisions: April 15, 2018.